210 related articles for article (PubMed ID: 21175569)
1. Ligand-induced internalization of the orexin OX(1) and cannabinoid CB(1) receptors assessed via N-terminal SNAP and CLIP-tagging.
Ward RJ; Pediani JD; Milligan G
Br J Pharmacol; 2011 Mar; 162(6):1439-52. PubMed ID: 21175569
[TBL] [Abstract][Full Text] [Related]
2. Heteromultimerization of cannabinoid CB(1) receptor and orexin OX(1) receptor generates a unique complex in which both protomers are regulated by orexin A.
Ward RJ; Pediani JD; Milligan G
J Biol Chem; 2011 Oct; 286(43):37414-28. PubMed ID: 21908614
[TBL] [Abstract][Full Text] [Related]
3. Activation of orexin 1 receptors in the periaqueductal gray of male rats leads to antinociception via retrograde endocannabinoid (2-arachidonoylglycerol)-induced disinhibition.
Ho YC; Lee HJ; Tung LW; Liao YY; Fu SY; Teng SF; Liao HT; Mackie K; Chiou LC
J Neurosci; 2011 Oct; 31(41):14600-10. PubMed ID: 21994376
[TBL] [Abstract][Full Text] [Related]
4. Orexin-1 receptor-cannabinoid CB1 receptor heterodimerization results in both ligand-dependent and -independent coordinated alterations of receptor localization and function.
Ellis J; Pediani JD; Canals M; Milasta S; Milligan G
J Biol Chem; 2006 Dec; 281(50):38812-24. PubMed ID: 17015451
[TBL] [Abstract][Full Text] [Related]
5. Orexins excite neurons of the rat cerebellar nucleus interpositus via orexin 2 receptors in vitro.
Yu L; Zhang XY; Zhang J; Zhu JN; Wang JJ
Cerebellum; 2010 Mar; 9(1):88-95. PubMed ID: 19921532
[TBL] [Abstract][Full Text] [Related]
6. Intramolecular fluorescence resonance energy transfer (FRET) sensors of the orexin OX1 and OX2 receptors identify slow kinetics of agonist activation.
Xu TR; Ward RJ; Pediani JD; Milligan G
J Biol Chem; 2012 Apr; 287(18):14937-49. PubMed ID: 22389503
[TBL] [Abstract][Full Text] [Related]
7. The orexin OX(1) receptor exists predominantly as a homodimer in the basal state: potential regulation of receptor organization by both agonist and antagonist ligands.
Xu TR; Ward RJ; Pediani JD; Milligan G
Biochem J; 2011 Oct; 439(1):171-83. PubMed ID: 21770891
[TBL] [Abstract][Full Text] [Related]
8. OX1 orexin/hypocretin receptor activation of phospholipase D.
Jäntti MH; Putula J; Somerharju P; Frohman MA; Kukkonen JP
Br J Pharmacol; 2012 Feb; 165(4b):1109-23. PubMed ID: 21718304
[TBL] [Abstract][Full Text] [Related]
9. Both orexin receptors are expressed in rat ovaries and fluctuate with the estrous cycle: effects of orexin receptor antagonists on gonadotropins and ovulation.
Silveyra P; Lux-Lantos V; Libertun C
Am J Physiol Endocrinol Metab; 2007 Oct; 293(4):E977-85. PubMed ID: 17638707
[TBL] [Abstract][Full Text] [Related]
10. Functional and binding kinetic studies make a distinction between OX1 and OX2 orexin receptor antagonists.
Faedo S; Perdonà E; Antolini M; di Fabio R; Merlo Pich E; Corsi M
Eur J Pharmacol; 2012 Oct; 692(1-3):1-9. PubMed ID: 22796453
[TBL] [Abstract][Full Text] [Related]
11. Autocrine endocannabinoid signaling through CB1 receptors potentiates OX1 orexin receptor signaling.
Jäntti MH; Putula J; Turunen PM; Näsman J; Reijonen S; Lindqvist C; Kukkonen JP
Mol Pharmacol; 2013 Mar; 83(3):621-32. PubMed ID: 23233488
[TBL] [Abstract][Full Text] [Related]
12. Orexin-A is composed of a highly conserved C-terminal and a specific, hydrophilic N-terminal region, revealing the structural basis of specific recognition by the orexin-1 receptor.
Takai T; Takaya T; Nakano M; Akutsu H; Nakagawa A; Aimoto S; Nagai K; Ikegami T
J Pept Sci; 2006 Jul; 12(7):443-54. PubMed ID: 16429482
[TBL] [Abstract][Full Text] [Related]
13. 3-Substituted pyrazole analogs of the cannabinoid type 1 (CB₁) receptor antagonist rimonabant: cannabinoid agonist-like effects in mice via non-CB₁, non-CB₂ mechanism.
Wiley JL; Selley DE; Wang P; Kottani R; Gadthula S; Mahadeven A
J Pharmacol Exp Ther; 2012 Feb; 340(2):433-44. PubMed ID: 22085649
[TBL] [Abstract][Full Text] [Related]
14. Mapping the binding pocket of dual antagonist almorexant to human orexin 1 and orexin 2 receptors: comparison with the selective OX1 antagonist SB-674042 and the selective OX2 antagonist N-ethyl-2-[(6-methoxy-pyridin-3-yl)-(toluene-2-sulfonyl)-amino]-N-pyridin-3-ylmethyl-acetamide (EMPA).
Malherbe P; Roche O; Marcuz A; Kratzeisen C; Wettstein JG; Bissantz C
Mol Pharmacol; 2010 Jul; 78(1):81-93. PubMed ID: 20404073
[TBL] [Abstract][Full Text] [Related]
15. Orexins/hypocretins: pain regulation and cellular actions.
Chiou LC; Lee HJ; Ho YC; Chen SP; Liao YY; Ma CH; Fan PC; Fuh JL; Wang SJ
Curr Pharm Des; 2010; 16(28):3089-100. PubMed ID: 20687883
[TBL] [Abstract][Full Text] [Related]
16. Dynein light chain Tctex-type 1 modulates orexin signaling through its interaction with orexin 1 receptor.
Duguay D; Bélanger-Nelson E; Mongrain V; Beben A; Khatchadourian A; Cermakian N
PLoS One; 2011; 6(10):e26430. PubMed ID: 22028875
[TBL] [Abstract][Full Text] [Related]
17. Orexins stimulate steroidogenic acute regulatory protein expression through multiple signaling pathways in human adrenal H295R cells.
Ramanjaneya M; Conner AC; Chen J; Stanfield PR; Randeva HS
Endocrinology; 2008 Aug; 149(8):4106-15. PubMed ID: 18450961
[TBL] [Abstract][Full Text] [Related]
18. Evidence for the role of hindbrain orexin-1 receptors in the control of meal size.
Parise EM; Lilly N; Kay K; Dossat AM; Seth R; Overton JM; Williams DL
Am J Physiol Regul Integr Comp Physiol; 2011 Dec; 301(6):R1692-9. PubMed ID: 21957165
[TBL] [Abstract][Full Text] [Related]
19. Biochemical and behavioural characterization of EMPA, a novel high-affinity, selective antagonist for the OX(2) receptor.
Malherbe P; Borroni E; Gobbi L; Knust H; Nettekoven M; Pinard E; Roche O; Rogers-Evans M; Wettstein JG; Moreau JL
Br J Pharmacol; 2009 Apr; 156(8):1326-41. PubMed ID: 19751316
[TBL] [Abstract][Full Text] [Related]
20. Effects of orexins A and B on expression of orexin receptors and progesterone release in luteal and granulosa ovarian cells.
Cataldi NI; Lux-Lantos VA; Libertun C
Regul Pept; 2012 Oct; 178(1-3):56-63. PubMed ID: 22749989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]